Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia

Background Wiskott–Aldrich syndrome (WAS) is a rare X‐linked immunodeficiency caused by defects of the WAS protein (WASP) gene. Patients with WAS typically demonstrate micro‐thrombocytopenia. Procedures The report describes seven male infants with WAS that initially presented with leukocytosis, mono...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric blood & cancer 2013-05, Vol.60 (5), p.836-841
Hauptverfasser: Yoshimi, Ayami, Kamachi, Yoshiro, Imai, Kosuke, Watanabe, Nobuhiro, Nakadate, Hisaya, Kanazawa, Takashi, Ozono, Shuichi, Kobayashi, Ryoji, Yoshida, Misa, Kobayashi, Chie, Hama, Asahito, Muramatsu, Hideki, Sasahara, Yoji, Jakob, Marcus, Morio, Tomohiro, Ehl, Stephan, Manabe, Atsushi, Niemeyer, Charlotte, Kojima, Seiji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 841
container_issue 5
container_start_page 836
container_title Pediatric blood & cancer
container_volume 60
creator Yoshimi, Ayami
Kamachi, Yoshiro
Imai, Kosuke
Watanabe, Nobuhiro
Nakadate, Hisaya
Kanazawa, Takashi
Ozono, Shuichi
Kobayashi, Ryoji
Yoshida, Misa
Kobayashi, Chie
Hama, Asahito
Muramatsu, Hideki
Sasahara, Yoji
Jakob, Marcus
Morio, Tomohiro
Ehl, Stephan
Manabe, Atsushi
Niemeyer, Charlotte
Kojima, Seiji
description Background Wiskott–Aldrich syndrome (WAS) is a rare X‐linked immunodeficiency caused by defects of the WAS protein (WASP) gene. Patients with WAS typically demonstrate micro‐thrombocytopenia. Procedures The report describes seven male infants with WAS that initially presented with leukocytosis, monocytosis, and myeloid and erythroid precursors in the peripheral blood (PB) and dysplasia in the bone marrow (BM), which was initially indistinguishable from juvenile myelomonocytic leukaemia (JMML). Results The median age of affected patients was 1 month (range, 1–4 months). Splenomegaly was absent in four of these patients, which was unusual for JMML. A mutation analysis of genes in the RAS‐signalling pathway did not support a diagnosis of JMML. Non‐haematological features, such as eczema (n = 7) and bloody stools (n = 6), ultimately led to the diagnosis of WAS at a median age of 4 months (range, 3–8 months), which was confirmed by absent (n = 6) or reduced (n = 1) WASP expression in lymphocytes by flow cytometry (FCM) and a WASP gene mutation. Interestingly, mean platelet volume (MPV) was normal in three of five patients and six of seven patients demonstrated occasional giant platelets, which was not compatible with WAS. Conclusions These data suggest that WAS should be considered in male infants presenting with JMML‐like features if no molecular markers of JMML can be detected. Pediatr Blood Cancer 2013; 60: 836–841. © 2012 Wiley Periodicals, Inc.
doi_str_mv 10.1002/pbc.24359
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1317832287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2920767101</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3069-fe80fa3f3ce3633a7ed6f087a2f6075fee583e63c208064b4c10cf0ea1016c943</originalsourceid><addsrcrecordid>eNp10E1v1DAQBmALgWhpOfAHUCQucEhre2I7eywr6CJVhUO_bpbXO269m8TBTij597jddg9IPXlkPfNq9BLygdEjRik_7pf2iFcgZq_IPhOVKAVl6vVuprM98i6ldaaSivot2eNAOSiQ--T22qdNGIbypFlFb--KNHWrGFos-ogJu8F3t8W9H-4KU9jGd96apui9HcaIRetbbzcPYj3-wc43-WvCJrShC3YavC0aHDcGW28OyRtnmoTvn94Dcvn928V8UZ79PP0xPzkrLVA5Kx3W1BlwYBEkgFG4ko7WynAnqRIOUdSAEiynNZXVsrKMWkfRMMqknVVwQD5vc_sYfo-YBt36ZLFpTIdhTJoBUzVwXqtMP_1H12GMXb7uUUkmRMWz-rJVNoaUIjrdR9-aOGlG9UP7OrevH9vP9uNT4rhscbWTz3VncLwF97mr6eUk_evr_Dmy3G74NODf3YaJGy0VKKGvz0_1Fb9RsLiq9AL-AY8Bnog</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1317615542</pqid></control><display><type>article</type><title>Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Yoshimi, Ayami ; Kamachi, Yoshiro ; Imai, Kosuke ; Watanabe, Nobuhiro ; Nakadate, Hisaya ; Kanazawa, Takashi ; Ozono, Shuichi ; Kobayashi, Ryoji ; Yoshida, Misa ; Kobayashi, Chie ; Hama, Asahito ; Muramatsu, Hideki ; Sasahara, Yoji ; Jakob, Marcus ; Morio, Tomohiro ; Ehl, Stephan ; Manabe, Atsushi ; Niemeyer, Charlotte ; Kojima, Seiji</creator><creatorcontrib>Yoshimi, Ayami ; Kamachi, Yoshiro ; Imai, Kosuke ; Watanabe, Nobuhiro ; Nakadate, Hisaya ; Kanazawa, Takashi ; Ozono, Shuichi ; Kobayashi, Ryoji ; Yoshida, Misa ; Kobayashi, Chie ; Hama, Asahito ; Muramatsu, Hideki ; Sasahara, Yoji ; Jakob, Marcus ; Morio, Tomohiro ; Ehl, Stephan ; Manabe, Atsushi ; Niemeyer, Charlotte ; Kojima, Seiji</creatorcontrib><description>Background Wiskott–Aldrich syndrome (WAS) is a rare X‐linked immunodeficiency caused by defects of the WAS protein (WASP) gene. Patients with WAS typically demonstrate micro‐thrombocytopenia. Procedures The report describes seven male infants with WAS that initially presented with leukocytosis, monocytosis, and myeloid and erythroid precursors in the peripheral blood (PB) and dysplasia in the bone marrow (BM), which was initially indistinguishable from juvenile myelomonocytic leukaemia (JMML). Results The median age of affected patients was 1 month (range, 1–4 months). Splenomegaly was absent in four of these patients, which was unusual for JMML. A mutation analysis of genes in the RAS‐signalling pathway did not support a diagnosis of JMML. Non‐haematological features, such as eczema (n = 7) and bloody stools (n = 6), ultimately led to the diagnosis of WAS at a median age of 4 months (range, 3–8 months), which was confirmed by absent (n = 6) or reduced (n = 1) WASP expression in lymphocytes by flow cytometry (FCM) and a WASP gene mutation. Interestingly, mean platelet volume (MPV) was normal in three of five patients and six of seven patients demonstrated occasional giant platelets, which was not compatible with WAS. Conclusions These data suggest that WAS should be considered in male infants presenting with JMML‐like features if no molecular markers of JMML can be detected. Pediatr Blood Cancer 2013; 60: 836–841. © 2012 Wiley Periodicals, Inc.</description><identifier>ISSN: 1545-5009</identifier><identifier>EISSN: 1545-5017</identifier><identifier>DOI: 10.1002/pbc.24359</identifier><identifier>PMID: 23023736</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Bone Marrow - pathology ; children ; Diagnosis, Differential ; DNA Mutational Analysis ; Erythroid Precursor Cells ; GTP Phosphohydrolases - genetics ; Hematology ; Humans ; Infant ; Infant, Newborn ; juvenile myelomonocytic leukaemia ; Leukemia, Myelomonocytic, Juvenile - diagnosis ; Leukemia, Myelomonocytic, Juvenile - genetics ; Leukocytosis - complications ; Male ; Membrane Proteins - genetics ; Myeloid Progenitor Cells ; Oncology ; Pediatrics ; Protein Tyrosine Phosphatase, Non-Receptor Type 11 - genetics ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins p21(ras) ; ras Proteins - genetics ; Thrombocytopenia ; Wiskott-Aldrich syndrome ; Wiskott-Aldrich Syndrome - blood ; Wiskott-Aldrich Syndrome - diagnosis ; Wiskott-Aldrich Syndrome - genetics ; Wiskott-Aldrich Syndrome Protein - genetics</subject><ispartof>Pediatric blood &amp; cancer, 2013-05, Vol.60 (5), p.836-841</ispartof><rights>Copyright © 2012 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3069-fe80fa3f3ce3633a7ed6f087a2f6075fee583e63c208064b4c10cf0ea1016c943</citedby><cites>FETCH-LOGICAL-c3069-fe80fa3f3ce3633a7ed6f087a2f6075fee583e63c208064b4c10cf0ea1016c943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpbc.24359$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpbc.24359$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23023736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoshimi, Ayami</creatorcontrib><creatorcontrib>Kamachi, Yoshiro</creatorcontrib><creatorcontrib>Imai, Kosuke</creatorcontrib><creatorcontrib>Watanabe, Nobuhiro</creatorcontrib><creatorcontrib>Nakadate, Hisaya</creatorcontrib><creatorcontrib>Kanazawa, Takashi</creatorcontrib><creatorcontrib>Ozono, Shuichi</creatorcontrib><creatorcontrib>Kobayashi, Ryoji</creatorcontrib><creatorcontrib>Yoshida, Misa</creatorcontrib><creatorcontrib>Kobayashi, Chie</creatorcontrib><creatorcontrib>Hama, Asahito</creatorcontrib><creatorcontrib>Muramatsu, Hideki</creatorcontrib><creatorcontrib>Sasahara, Yoji</creatorcontrib><creatorcontrib>Jakob, Marcus</creatorcontrib><creatorcontrib>Morio, Tomohiro</creatorcontrib><creatorcontrib>Ehl, Stephan</creatorcontrib><creatorcontrib>Manabe, Atsushi</creatorcontrib><creatorcontrib>Niemeyer, Charlotte</creatorcontrib><creatorcontrib>Kojima, Seiji</creatorcontrib><title>Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia</title><title>Pediatric blood &amp; cancer</title><addtitle>Pediatr. Blood Cancer</addtitle><description>Background Wiskott–Aldrich syndrome (WAS) is a rare X‐linked immunodeficiency caused by defects of the WAS protein (WASP) gene. Patients with WAS typically demonstrate micro‐thrombocytopenia. Procedures The report describes seven male infants with WAS that initially presented with leukocytosis, monocytosis, and myeloid and erythroid precursors in the peripheral blood (PB) and dysplasia in the bone marrow (BM), which was initially indistinguishable from juvenile myelomonocytic leukaemia (JMML). Results The median age of affected patients was 1 month (range, 1–4 months). Splenomegaly was absent in four of these patients, which was unusual for JMML. A mutation analysis of genes in the RAS‐signalling pathway did not support a diagnosis of JMML. Non‐haematological features, such as eczema (n = 7) and bloody stools (n = 6), ultimately led to the diagnosis of WAS at a median age of 4 months (range, 3–8 months), which was confirmed by absent (n = 6) or reduced (n = 1) WASP expression in lymphocytes by flow cytometry (FCM) and a WASP gene mutation. Interestingly, mean platelet volume (MPV) was normal in three of five patients and six of seven patients demonstrated occasional giant platelets, which was not compatible with WAS. Conclusions These data suggest that WAS should be considered in male infants presenting with JMML‐like features if no molecular markers of JMML can be detected. Pediatr Blood Cancer 2013; 60: 836–841. © 2012 Wiley Periodicals, Inc.</description><subject>Bone Marrow - pathology</subject><subject>children</subject><subject>Diagnosis, Differential</subject><subject>DNA Mutational Analysis</subject><subject>Erythroid Precursor Cells</subject><subject>GTP Phosphohydrolases - genetics</subject><subject>Hematology</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>juvenile myelomonocytic leukaemia</subject><subject>Leukemia, Myelomonocytic, Juvenile - diagnosis</subject><subject>Leukemia, Myelomonocytic, Juvenile - genetics</subject><subject>Leukocytosis - complications</subject><subject>Male</subject><subject>Membrane Proteins - genetics</subject><subject>Myeloid Progenitor Cells</subject><subject>Oncology</subject><subject>Pediatrics</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 11 - genetics</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins p21(ras)</subject><subject>ras Proteins - genetics</subject><subject>Thrombocytopenia</subject><subject>Wiskott-Aldrich syndrome</subject><subject>Wiskott-Aldrich Syndrome - blood</subject><subject>Wiskott-Aldrich Syndrome - diagnosis</subject><subject>Wiskott-Aldrich Syndrome - genetics</subject><subject>Wiskott-Aldrich Syndrome Protein - genetics</subject><issn>1545-5009</issn><issn>1545-5017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10E1v1DAQBmALgWhpOfAHUCQucEhre2I7eywr6CJVhUO_bpbXO269m8TBTij597jddg9IPXlkPfNq9BLygdEjRik_7pf2iFcgZq_IPhOVKAVl6vVuprM98i6ldaaSivot2eNAOSiQ--T22qdNGIbypFlFb--KNHWrGFos-ogJu8F3t8W9H-4KU9jGd96apui9HcaIRetbbzcPYj3-wc43-WvCJrShC3YavC0aHDcGW28OyRtnmoTvn94Dcvn928V8UZ79PP0xPzkrLVA5Kx3W1BlwYBEkgFG4ko7WynAnqRIOUdSAEiynNZXVsrKMWkfRMMqknVVwQD5vc_sYfo-YBt36ZLFpTIdhTJoBUzVwXqtMP_1H12GMXb7uUUkmRMWz-rJVNoaUIjrdR9-aOGlG9UP7OrevH9vP9uNT4rhscbWTz3VncLwF97mr6eUk_evr_Dmy3G74NODf3YaJGy0VKKGvz0_1Fb9RsLiq9AL-AY8Bnog</recordid><startdate>201305</startdate><enddate>201305</enddate><creator>Yoshimi, Ayami</creator><creator>Kamachi, Yoshiro</creator><creator>Imai, Kosuke</creator><creator>Watanabe, Nobuhiro</creator><creator>Nakadate, Hisaya</creator><creator>Kanazawa, Takashi</creator><creator>Ozono, Shuichi</creator><creator>Kobayashi, Ryoji</creator><creator>Yoshida, Misa</creator><creator>Kobayashi, Chie</creator><creator>Hama, Asahito</creator><creator>Muramatsu, Hideki</creator><creator>Sasahara, Yoji</creator><creator>Jakob, Marcus</creator><creator>Morio, Tomohiro</creator><creator>Ehl, Stephan</creator><creator>Manabe, Atsushi</creator><creator>Niemeyer, Charlotte</creator><creator>Kojima, Seiji</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201305</creationdate><title>Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia</title><author>Yoshimi, Ayami ; Kamachi, Yoshiro ; Imai, Kosuke ; Watanabe, Nobuhiro ; Nakadate, Hisaya ; Kanazawa, Takashi ; Ozono, Shuichi ; Kobayashi, Ryoji ; Yoshida, Misa ; Kobayashi, Chie ; Hama, Asahito ; Muramatsu, Hideki ; Sasahara, Yoji ; Jakob, Marcus ; Morio, Tomohiro ; Ehl, Stephan ; Manabe, Atsushi ; Niemeyer, Charlotte ; Kojima, Seiji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3069-fe80fa3f3ce3633a7ed6f087a2f6075fee583e63c208064b4c10cf0ea1016c943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Bone Marrow - pathology</topic><topic>children</topic><topic>Diagnosis, Differential</topic><topic>DNA Mutational Analysis</topic><topic>Erythroid Precursor Cells</topic><topic>GTP Phosphohydrolases - genetics</topic><topic>Hematology</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>juvenile myelomonocytic leukaemia</topic><topic>Leukemia, Myelomonocytic, Juvenile - diagnosis</topic><topic>Leukemia, Myelomonocytic, Juvenile - genetics</topic><topic>Leukocytosis - complications</topic><topic>Male</topic><topic>Membrane Proteins - genetics</topic><topic>Myeloid Progenitor Cells</topic><topic>Oncology</topic><topic>Pediatrics</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 11 - genetics</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins p21(ras)</topic><topic>ras Proteins - genetics</topic><topic>Thrombocytopenia</topic><topic>Wiskott-Aldrich syndrome</topic><topic>Wiskott-Aldrich Syndrome - blood</topic><topic>Wiskott-Aldrich Syndrome - diagnosis</topic><topic>Wiskott-Aldrich Syndrome - genetics</topic><topic>Wiskott-Aldrich Syndrome Protein - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoshimi, Ayami</creatorcontrib><creatorcontrib>Kamachi, Yoshiro</creatorcontrib><creatorcontrib>Imai, Kosuke</creatorcontrib><creatorcontrib>Watanabe, Nobuhiro</creatorcontrib><creatorcontrib>Nakadate, Hisaya</creatorcontrib><creatorcontrib>Kanazawa, Takashi</creatorcontrib><creatorcontrib>Ozono, Shuichi</creatorcontrib><creatorcontrib>Kobayashi, Ryoji</creatorcontrib><creatorcontrib>Yoshida, Misa</creatorcontrib><creatorcontrib>Kobayashi, Chie</creatorcontrib><creatorcontrib>Hama, Asahito</creatorcontrib><creatorcontrib>Muramatsu, Hideki</creatorcontrib><creatorcontrib>Sasahara, Yoji</creatorcontrib><creatorcontrib>Jakob, Marcus</creatorcontrib><creatorcontrib>Morio, Tomohiro</creatorcontrib><creatorcontrib>Ehl, Stephan</creatorcontrib><creatorcontrib>Manabe, Atsushi</creatorcontrib><creatorcontrib>Niemeyer, Charlotte</creatorcontrib><creatorcontrib>Kojima, Seiji</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric blood &amp; cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoshimi, Ayami</au><au>Kamachi, Yoshiro</au><au>Imai, Kosuke</au><au>Watanabe, Nobuhiro</au><au>Nakadate, Hisaya</au><au>Kanazawa, Takashi</au><au>Ozono, Shuichi</au><au>Kobayashi, Ryoji</au><au>Yoshida, Misa</au><au>Kobayashi, Chie</au><au>Hama, Asahito</au><au>Muramatsu, Hideki</au><au>Sasahara, Yoji</au><au>Jakob, Marcus</au><au>Morio, Tomohiro</au><au>Ehl, Stephan</au><au>Manabe, Atsushi</au><au>Niemeyer, Charlotte</au><au>Kojima, Seiji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia</atitle><jtitle>Pediatric blood &amp; cancer</jtitle><addtitle>Pediatr. Blood Cancer</addtitle><date>2013-05</date><risdate>2013</risdate><volume>60</volume><issue>5</issue><spage>836</spage><epage>841</epage><pages>836-841</pages><issn>1545-5009</issn><eissn>1545-5017</eissn><abstract>Background Wiskott–Aldrich syndrome (WAS) is a rare X‐linked immunodeficiency caused by defects of the WAS protein (WASP) gene. Patients with WAS typically demonstrate micro‐thrombocytopenia. Procedures The report describes seven male infants with WAS that initially presented with leukocytosis, monocytosis, and myeloid and erythroid precursors in the peripheral blood (PB) and dysplasia in the bone marrow (BM), which was initially indistinguishable from juvenile myelomonocytic leukaemia (JMML). Results The median age of affected patients was 1 month (range, 1–4 months). Splenomegaly was absent in four of these patients, which was unusual for JMML. A mutation analysis of genes in the RAS‐signalling pathway did not support a diagnosis of JMML. Non‐haematological features, such as eczema (n = 7) and bloody stools (n = 6), ultimately led to the diagnosis of WAS at a median age of 4 months (range, 3–8 months), which was confirmed by absent (n = 6) or reduced (n = 1) WASP expression in lymphocytes by flow cytometry (FCM) and a WASP gene mutation. Interestingly, mean platelet volume (MPV) was normal in three of five patients and six of seven patients demonstrated occasional giant platelets, which was not compatible with WAS. Conclusions These data suggest that WAS should be considered in male infants presenting with JMML‐like features if no molecular markers of JMML can be detected. Pediatr Blood Cancer 2013; 60: 836–841. © 2012 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>23023736</pmid><doi>10.1002/pbc.24359</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1545-5009
ispartof Pediatric blood & cancer, 2013-05, Vol.60 (5), p.836-841
issn 1545-5009
1545-5017
language eng
recordid cdi_proquest_miscellaneous_1317832287
source MEDLINE; Wiley Online Library All Journals
subjects Bone Marrow - pathology
children
Diagnosis, Differential
DNA Mutational Analysis
Erythroid Precursor Cells
GTP Phosphohydrolases - genetics
Hematology
Humans
Infant
Infant, Newborn
juvenile myelomonocytic leukaemia
Leukemia, Myelomonocytic, Juvenile - diagnosis
Leukemia, Myelomonocytic, Juvenile - genetics
Leukocytosis - complications
Male
Membrane Proteins - genetics
Myeloid Progenitor Cells
Oncology
Pediatrics
Protein Tyrosine Phosphatase, Non-Receptor Type 11 - genetics
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins p21(ras)
ras Proteins - genetics
Thrombocytopenia
Wiskott-Aldrich syndrome
Wiskott-Aldrich Syndrome - blood
Wiskott-Aldrich Syndrome - diagnosis
Wiskott-Aldrich Syndrome - genetics
Wiskott-Aldrich Syndrome Protein - genetics
title Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T13%3A55%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Wiskott-Aldrich%20syndrome%20presenting%20with%20a%20clinical%20picture%20mimicking%20juvenile%20myelomonocytic%20leukaemia&rft.jtitle=Pediatric%20blood%20&%20cancer&rft.au=Yoshimi,%20Ayami&rft.date=2013-05&rft.volume=60&rft.issue=5&rft.spage=836&rft.epage=841&rft.pages=836-841&rft.issn=1545-5009&rft.eissn=1545-5017&rft_id=info:doi/10.1002/pbc.24359&rft_dat=%3Cproquest_cross%3E2920767101%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1317615542&rft_id=info:pmid/23023736&rfr_iscdi=true